A prospective study of patients undergoing trabecular micro-bypass implantation with iStent or iStent inject® at the time of cataract surgery shows clinically and statistically significant improvements in ocular surface disease (OSD), including tear break-up time, corneal/conjunctival staining, and Ocular Surface Disease Index scores (OSDI).
All webinars will be live and interactive at 7.30pm to 8.30pm.
1 Interactive CPD Point is available for all webinars and is applied for via the GOC and RCO.
Confirmed Speaker: Mr Simon Dulku, MA, Pathology, MBBS, FRCOphth, MRCOphth
The SCHWIND AMARIS product family proves to be a constant model for success in corneal surgery and continues to be in high demand worldwide. Around 1,200 AMARIS eximer lasers have been installed in 100 countries so far. Whether in Africa, Asia, Australia and Oceania, Europe, North or South America: SCHWIND users have...